ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
38.13
-0.37%
US Tech 100
19,395.14
0.38%
S&P 500
5,728.35
0.17%
US Dollar vs CAD
1.3439
-0.67%
Bitcoin
63,838.00
0.81%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Zentalis Pharmaceuticals Inc (ZNTL)

  7. Zentalis Pharmaceuticals Inc (ZNTL) News

ZNTL

Zentalis Pharmaceuticals (ZNTL)

Zentalis Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ZNTL
DateTimeSourceHeadlineSymbolCompany
09/16/20248:38PMPR Newswire (US)Kuehn Law Encourages Investors of Zentalis Pharmaceuticals, Inc. to Contact Law FirmNASDAQ:ZNTLZentalis Pharmaceuticals Inc
09/16/20246:02AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ZNTLZentalis Pharmaceuticals Inc
09/16/20246:00AMGlobeNewswire Inc.Zentalis Pharmaceuticals Announces FDA Has Lifted Partial Clinical Hold on Azenosertib StudiesNASDAQ:ZNTLZentalis Pharmaceuticals Inc
09/09/20246:00AMGlobeNewswire Inc.Zentalis Pharmaceuticals to Present Preclinical Azenosertib Data at ESMO 2024NASDAQ:ZNTLZentalis Pharmaceuticals Inc
09/03/20243:40PMGlobeNewswire Inc.Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ZNTLZentalis Pharmaceuticals Inc
08/19/20243:55PMBusiness WireNewman Ferrara LLP Announces Corporate Governance Investigation of Zentalis Pharmaceuticals, Inc. – ZNTLNASDAQ:ZNTLZentalis Pharmaceuticals Inc
08/09/20246:03AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ZNTLZentalis Pharmaceuticals Inc
08/09/20246:01AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ZNTLZentalis Pharmaceuticals Inc
08/09/20246:00AMGlobeNewswire Inc.Zentalis Pharmaceuticals Reports Second Quarter 2024 Financial Results and Operational ProgressNASDAQ:ZNTLZentalis Pharmaceuticals Inc
08/01/20245:00PMGlobeNewswire Inc.Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ZNTLZentalis Pharmaceuticals Inc
07/25/20241:49PMPR Newswire (US)Kuehn Law Encourages Investors of Zentalis Pharmaceuticals, Inc. to Contact Law FirmNASDAQ:ZNTLZentalis Pharmaceuticals Inc
07/01/20245:00PMGlobeNewswire Inc.Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ZNTLZentalis Pharmaceuticals Inc
06/18/20246:00AMGlobeNewswire Inc.Zentalis Pharmaceuticals Provides Update on Azenosertib Clinical Development ProgramNASDAQ:ZNTLZentalis Pharmaceuticals Inc
06/03/20245:00PMGlobeNewswire Inc.Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ZNTLZentalis Pharmaceuticals Inc
06/03/20246:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ZNTLZentalis Pharmaceuticals Inc
05/30/20246:00AMGlobeNewswire Inc.Zentalis Pharmaceuticals to Present at the Jefferies Global Healthcare ConferenceNASDAQ:ZNTLZentalis Pharmaceuticals Inc
05/29/20246:16AMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:ZNTLZentalis Pharmaceuticals Inc
05/29/20246:04AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ZNTLZentalis Pharmaceuticals Inc
05/29/20246:00AMGlobeNewswire Inc.Zentalis Pharmaceuticals Announces Appointment of Accomplished Oncology Drug Developer Luke Walker, M.D., to Board of DirectorsNASDAQ:ZNTLZentalis Pharmaceuticals Inc
05/23/20244:01PMGlobeNewswire Inc.Zentalis Pharmaceuticals to Present Promising Results from Phase 1 Trial of Azenosertib and Gemcitabine in Relapsed or Refractory Osteosarcoma at 2024 American Society of Clinical Oncology Annual MeetingNASDAQ:ZNTLZentalis Pharmaceuticals Inc
05/14/20246:00AMGlobeNewswire Inc.Zentalis Pharmaceuticals to Present at TD Cowen 5th Annual Oncology Innovation SummitNASDAQ:ZNTLZentalis Pharmaceuticals Inc
05/07/20246:05AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ZNTLZentalis Pharmaceuticals Inc
05/07/20246:03AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ZNTLZentalis Pharmaceuticals Inc
05/07/20246:00AMGlobeNewswire Inc.Zentalis Pharmaceuticals Reports First Quarter 2024 Financial Results and Operational ProgressNASDAQ:ZNTLZentalis Pharmaceuticals Inc
05/01/20244:30PMGlobeNewswire Inc.Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ZNTLZentalis Pharmaceuticals Inc
04/02/20243:05PMGlobeNewswire Inc.Zentalis Pharmaceuticals to Highlight Preclinical Data Demonstrating that WEE1 Inhibitor Azenosertib Exerts Synergistic Anti-tumor Activity with KRAS(G12C) Inhibitors at AACR Annual Meeting 2024NASDAQ:ZNTLZentalis Pharmaceuticals Inc
04/01/20244:30PMGlobeNewswire Inc.Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ZNTLZentalis Pharmaceuticals Inc
03/01/20245:00PMGlobeNewswire Inc.Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ZNTLZentalis Pharmaceuticals Inc
02/29/20244:20PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:ZNTLZentalis Pharmaceuticals Inc
02/29/20244:14PMEdgar (US Regulatory)Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuersNASDAQ:ZNTLZentalis Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:ZNTL

Your Recent History

ASX
GFLN
NASDAQ
FOLD
Amicus Therapeutics
TG
A19JPD
Caixabank
AMEX
EVLN
Eaton Vance Floating Rat...
LSE
FB07
Sg Issuer 28
LSE
43FR
Rep. Ghana 29 R
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved